Moderna
MRNA
#1187
Rank
โ‚ฌ15.11 B
Marketcap
39,27ย โ‚ฌ
Share price
7.48%
Change (1 day)
-45.29%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚ฌ15.11 Billion

As of November 2024 Moderna has a market cap of โ‚ฌ15.11 Billion. This makes Moderna the world's 1187th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ15.11 B-55.95%
2023โ‚ฌ34.30 B-46.68%
2022โ‚ฌ64.33 B-29.25%
2021โ‚ฌ90.92 B170.54%
2020โ‚ฌ33.60 B471.97%
2019โ‚ฌ5.87 B33.89%
2018โ‚ฌ4.38 B

End of Day market cap according to different sources

On Nov 22nd, 2024 the market cap of Moderna was reported to be:

โ‚ฌ15.11 Billion
by Yahoo Finance info icon info icon
โ‚ฌ15.11 Billion
by CompaniesMarketCap info icon info icon
โ‚ฌ15.11 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ91.96 M-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ239.64 B 1,485.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.79 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.17 B 99.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ199.13 B 1,217.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ2.20 B-85.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ356.84 B 2,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.84 B-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA